Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

+21.20%
3Y annualised
-0.49% 1D
NAV: 16 Nov '26
₹25.15
Min. for SIP
--
Fund size (AUM)
₹202.88 Cr
Expense ratio
1.10%
Rating
3

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
6 months₹30,000₹32,199
+7.33%
1 year₹60,000₹68,347
+13.91%
3 years₹1,80,000₹2,32,556
+29.20%
5 years₹3,00,000₹4,74,724
+58.24%

Holdings (48)

NameSectorInstrumentsAssets
Sun Pharmaceutical Industries LtdHealthcareEquity9.68%
Eli Lilly Forgn. Eq (LLY)HealthcareForeign - Equity7.33%
Divi's Laboratories LtdHealthcareEquity7.07%
Apollo Hospitals Enterprise LtdHealthcareEquity5.15%
Laurus Labs LtdHealthcareEquity5.11%
Johnson & Johnson Ltd. Forgn. Eq (JNJ)HealthcareForeign - Equity4.25%
Cipla LtdHealthcareEquity4.22%
Dr. Reddy's Laboratories LtdHealthcareEquity4.10%
Torrent Pharmaceuticals LtdHealthcareEquity3.98%
Max Healthcare Institute LtdHealthcareEquity3.67%
AbbVie Inc Forgn. Eq (ABBV)HealthcareForeign - Equity3.36%
Lupin LtdHealthcareEquity2.78%
Aurobindo Pharma LtdHealthcareEquity2.64%
Merck & Co Inc (US) Forgn. Eq (MRK)HealthcareForeign - Equity2.38%
Fortis Healthcare LtdHealthcareEquity2.28%
Glenmark Pharmaceuticals LtdHealthcareEquity1.96%
Novartis AG ADS/ADR (NVS)HealthcareADS/ADR1.90%
Thermo Fisher Scientific Inc Forgn. Eq (TMO)HealthcareForeign - Equity1.67%
Ipca Laboratories LtdHealthcareEquity1.63%
Amgen Inc. (USA) Forgn. Eq (AMGN)HealthcareForeign - Equity1.62%
Mankind Pharma Ltd.HealthcareEquity1.56%
Others CBLOUnspecifiedCBLO1.43%
Zydus Lifesciences LtdHealthcareEquity1.39%
Gland Pharma LtdHealthcareEquity1.39%
Gilead Sciences Inc. (USA) Forgn. Eq (GILD)HealthcareForeign - Equity1.37%
Alkem Laboratories LtdHealthcareEquity1.30%
Biocon LtdHealthcareEquity1.29%
Aster DM Healthcare LtdHealthcareEquity1.19%
Abbott Laboratories Forgn. Eq (ABT)HealthcareForeign - Equity1.19%
Intuitive Surgical Inc. (USA) Forgn. Eq (ISRG)HealthcareForeign - Equity0.99%
Danaher Corporation Forgn. Eq (DHR)HealthcareForeign - Equity0.96%
Ajanta Pharma LtdHealthcareEquity0.93%
Vertex Pharmaceuticals Inc. (USA) Forgn. Eq (VRTX)HealthcareForeign - Equity0.92%
Wockhardt LtdHealthcareEquity0.84%
Novo Nordisk A/S Forgn. Eq (NVO)HealthcareADS/ADR0.83%
Medtronic Forgn. Eq (MDT)HealthcareForeign - Equity0.80%
Stryker Corp Forgn. Eq (SYK)HealthcareForeign - Equity0.65%
Narayana Hrudayalaya LtdHealthcareEquity0.63%
Global Health LtdHealthcareEquity0.62%
Regeneron Pharmaceuticals Inc Forgn. Eq (REGN)HealthcareForeign - Equity0.62%
Glaxosmithkline Pharmaceuticals LtdHealthcareEquity0.58%
Anthem Biosciences Ltd.HealthcareEquity0.54%
Becton Dickinson And Co Forgn. Eq (BDX)HealthcareForeign - Equity0.35%
Agilent Technologies Inc Forgn. Eq (A)HealthcareForeign - Equity0.32%
Iqvia Holdings Forgn. Eq (IQV)HealthcareForeign - Equity0.29%
Waters Corporation (WAT)HealthcareForeign - Equity0.29%
CashUnspecifiedCash0.00%
Net PayablesUnspecifiedNet Payables-0.05%

Minimum investments

Min. for 1st investment
₹100
Min. for 2nd investment
₹100
Min. for SIP
--

Returns and rankings

Name1Y3Y5YAll
Fund returns+22.0%+21.2%+15.1%+16.6%
Category average (Equity Sectoral)+18.6%+21.5%+15.6%+17.1%
Rank (Equity Sectoral)1099--

Exit load, stamp duty and tax

Exit load

Nil

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

Education
Mr. Jain is a MMS (Finance) from Mumbai University.
Experience
Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.
Also manages these schemes

About Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth is a Equity Mutual Fund Scheme launched by Edelweiss Mutual Fund. This scheme was made available to investors on 30 Apr 2008. Amit Vora is the Current Fund Manager of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth fund. The fund currently has an Asset Under Management(AUM) of ₹1,76,099 Cr and the Latest NAV as of 16 Nov 2026 is ₹25.15. The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Growth is rated Very High risk. Minimum SIP Investment is set to ₹100. Minimum Lumpsum Investment is ₹100. ;

Investment Objective

The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
Fund benchmarkMSCI India Domestic & World Healthcare 45 Index

Fund house

Rank (total assets)#15 in India
Total AUM₹1,76,099.44 Cr
Date of Incorporation30 Apr 2008
Phone+91 22 4093 3400
E-mail--
Launch Date30 Apr 2008
AddressEdelweiss HouseOff C.S.T. Road,Kalina Mumbai 400098
CustodianStandard Chartered Bank
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,